Myeloma 2016

Myeloma 2016

View all videos
MMRF presents highlights for patients at Myeloma 2016 5:17
MMRF presents highlights for patients at Myeloma 2016
Daniel Auclair et al. • 22 Apr 2016
Isatuximab for multiple myeloma – promising results and next steps 2:20
Isatuximab for multiple myeloma – promising results and next steps
Thomas Martin • 22 Apr 2016
Tolerability of monoclonal antibodies in multiple myeloma 1:13
Tolerability of monoclonal antibodies in multiple myeloma
Thomas Martin • 22 Apr 2016
The biology of the plasma cell and drug targets in multiple myeloma 1:07
The biology of the plasma cell and drug targets in multiple myeloma
Lawrence Boise • 22 Apr 2016
Clinical management of venetoclax in multiple myeloma 1:28
Clinical management of venetoclax in multiple myeloma
Lawrence Boise • 22 Apr 2016
The importance of the microenvironment in multiple myeloma 1:08
The importance of the microenvironment in multiple myeloma
Faith Davies • 22 Apr 2016
Perspectives on future paths to cure multiple myeloma 1:36
Perspectives on future paths to cure multiple myeloma
Antonio Palumbo • 22 Apr 2016
Update on trametinib for multiple myeloma 2:14
Update on trametinib for multiple myeloma
Faith Davies • 22 Apr 2016
LCL161 – a new approach to treating multiple myeloma 4:42
LCL161 – a new approach to treating multiple myeloma
Marta Chesi • 22 Apr 2016
Mechanism of action of daratumumab 2:03
Mechanism of action of daratumumab
Niels van de Donk • 22 Apr 2016
Myeloma 2016: Panel discussion on novel treatments 13:09
Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al. • 22 Apr 2016
Myeloma 2016: Panel discussion on the new treatment paradigm 11:57
Myeloma 2016: Panel discussion on the new treatment paradigm
Gareth Morgan et al.
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma 3:06
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma
Jesús San Miguel • 22 Apr 2016
PET-CT vs MRI in multiple myeloma 1:59
PET-CT vs MRI in multiple myeloma
Philippe Moreau • 22 Apr 2016
The impact of new drugs and the changing role of transplants in multiple myeloma 3:58
The impact of new drugs and the changing role of transplants in multiple myeloma
Paul Richardson • 22 Apr 2016
What role will minimal residual disease testing play in multiple myeloma? 3:58
What role will minimal residual disease testing play in multiple myeloma?
Ola Landgren • 22 Apr 2016
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals